Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions-Reference-Cited by-同舟云学术

Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions

Published:2014-06 Issue:2 Volume:19 Page:88-103
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripher Nerv Syst

Author:

Blum Stefan¹,McCombe Pamela A.¹

Affiliation:

1. The University of Queensland Centre for Clinical Research; UQ CCR; Queensland Australia

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jns5.12074/fullpdf

Reference155 articles.

1. HLA antigens in chronic relapsing idiopathic inflammatory polyneuropathy;Adams;J Neurol Neurosurg Psychiatry,1979

2. HLA antigens in Guillain-Barré syndrome;Adams;Lancet,1977

3. Guillain-Barre syndrome in a patient with hereditary spastic paraparesis. A case report;Alhashel;Med Princ Pract,2004

4. Guillain Barre syndrome in a family: a case report of four siblings;Aquil;J Coll Physicians Surg Pak,2011

5. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis;Asbury;Medicine (Baltimore),1969

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy;Journal of Neuroimmunology;2024-07

2. Exploring the depths of IgG4: insights into autoimmunity and novel treatments;Frontiers in Immunology;2024-04-18

3. A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute‐onset chronic inflammatory demyelinating polyneuropathy;European Journal of Neurology;2024-02-14

4. Guillain-Barré Syndrome and Neurocritical Care;Principles and Practice of Neurocritical Care;2024

5. Guillain-Barré Syndrome;Neuroimmune Diseases;2024